Ironshore Pharmaceuticals & Development, Inc. has joined the 2018 Cayman Islands Healthcare Conference from Oct. 18 to 20 as a Premium Plus Sponsor.
The conference at The Ritz-Carlton, Grand Cayman is held under the theme “Managing Your Health: The Empowered Patient.” It will cover topics such as the day-to-day management of non-communicable diseases, understanding when health symptoms indicate a trip to the emergency room, as well as developments in technology and its impact on healthcare in Cayman.
Lizzette Yearwood, chair of the Conference Planning Committee and CEO of the Cayman Islands Health Services Authority, welcomed the support of Ironshore Pharmaceuticals.
“To have attracted the support of a partner of this caliber is a testimony to the significance of the conference and its growth over the past nine years,” Ms. Yearwood said.
Based in Grand Cayman, Ironshore is a pharmaceutical company responsible for managing and directing all research, development and manufacturing activities for its drug candidates. It is a wholly owned subsidiary of Toronto-based Highland Therapeutics Inc..
“We are looking forward to sharing with the public some exciting developments that we have, as we continue to find ways to revolutionise the delivery of healthcare in a modern world,” said David Lickrish, president and CEO of Ironshore Pharmaceuticals. The conference is free to attendees.
Other sponsors include the Health Services Authority, the Ministry of Health, Tower, Pinnacle Media, Jackson Memorial Hospital, UHealth International, BAF Insurance, CINICO, 3T Cayman, Holy Cross Hospital, Pan-American Life Insurance Company of the Cayman Islands, The Wellness Centre, Health City Cayman Islands, The Cayman Hearing Center, MARSH, Baptist Health, Dart and Aetna.
Full conference agenda, speakers and sponsorship details can be found on the conference website at www.healthcareconference.ky.